3 smart ideas for vaccinating the skeptics
With new cases of COVID-19 rising again nationally (and surging quite seriously in certain regions of the country), American pundits have turned their attention to solving the riddle of how to persuade vaccine skeptics to take the plunge, get the shot, and protect themselves and those around them against the highly contagious Delta variant of the disease.
Three ideas stand out as especially smart.
Approve the vaccines. If it sounds strange to say that the FDA should approve the Pfizer/BioNTech and Moderna vaccines for use when millions of Americans have already received the shots, that's because what the FDA has been doing makes little sense. As The Week's own Noah Millman has argued, followed by Matthew Yglesias on Substack, nothing would do more to persuade skeptics that the vaccines are safe, and to encourage vaccine mandates in a range of public institutions (including the military and schools), than the FDA issuing final approval for their use. (On Monday, a federal judge upheld Indiana University's vaccine mandate, so FDA approval isn't a necessary condition of imposing and enforcing such mandates. But such approval would likely make them far more widespread.) Yes, this would mean fast-tracking the decision, but the agency already issued emergency-use approval of the vaccines in record time. That was many millions of shots ago. The vaccines work. Why not get this done now?
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Stop fighting the culture war. National Review's Michael Brendan Dougherty suggests that the most effective thing people promoting the vaccines could do is something negative — stop disrespecting the vaccine-hesitant by calling them idiots or moral defectives. Instead, those pushing the vaccines should demonstrate some empathy and understanding toward those who have reacted to well over a year of shifting "expert" counsel about how to respond to the pandemic by deciding to sit on the sidelines for a while, patiently waiting to see what happens to those who leapt to the front of the vaccination line. That soft touch might just get them to soften their own resistance.
Cough up the cash. Building on Dougherty's arguments, The New York Times' Ross Douthat proposes that governments would have more luck persuading people to get vaccinated if they combined rhetorical honey with a financial incentive: $100 for getting the first of two shots followed by $1,000 for showing up for the second. For "a rounding error in the Biden infrastructure plan," such a program could make a huge difference in motivating people to come off the vaccination fence, especially if it were presented as "a limited-time offer, good only through October." Free money? Now that just might work.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Damon Linker is a senior correspondent at TheWeek.com. He is also a former contributing editor at The New Republic and the author of The Theocons and The Religious Test.
-
Why more and more adults are reaching for soft toys
Under The Radar Does the popularity of the Squishmallow show Gen Z are 'scared to grow up'?
By Chas Newkey-Burden, The Week UK Published
-
Magazine solutions - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
Magazine printables - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
Should we be worried about declining birth rates?
Talking Points Baby boom or bust
By Devika Rao, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Are men the problem with male contraception?
Talking Points Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility
By Chas Newkey-Burden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published